What is the appropriate dosage and treatment duration of Cloxacillin (dicloxacillin) for pediatric patients with suspected or confirmed bacterial infections, particularly those with a history of allergies or sensitivities to penicillin or other antibiotics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cloxacillin Dosing for Pediatric Bacterial Infections

For pediatric patients with suspected or confirmed staphylococcal skin and soft tissue infections, oral cloxacillin (or dicloxacillin) should be dosed at 25-50 mg/kg/day divided into 4 doses, with intravenous cloxacillin/flucloxacillin at 50 mg/kg every 6 hours (QDS) for severe infections requiring parenteral therapy. 1

Oral Dosing for Outpatient Management

  • For impetigo and uncomplicated skin infections: Dicloxacillin 25-50 mg/kg/day divided into 4 doses orally is the standard pediatric dosing 1
  • For methicillin-susceptible Staphylococcus aureus (MSSA) skin and soft tissue infections: The same dosing applies (25-50 mg/kg/day in 4 divided doses) 1
  • Treatment duration: Typically 7-10 days depending on clinical response 1

Important caveat: Dicloxacillin is noted as "not used much in pediatrics" in current U.S. practice, with cephalexin (25-50 mg/kg/day in 3-4 divided doses) being preferred due to better suspension availability and less frequent dosing requirements 1

Intravenous Dosing for Severe Infections

  • For mastoiditis: Cloxacillin/flucloxacillin 50 mg/kg QDS (every 6 hours) IV for 10 days 1
  • For osteomyelitis (age >3 years): Cloxacillin/flucloxacillin 50 mg/kg QDS IV for 10 days, then switch to oral therapy (total 3 weeks) 1
  • For suspected staphylococcal pneumonia: Cloxacillin 50 mg/kg QDS IV for 7-10 days, then switch to oral (total 3 weeks therapy) 1
  • For infant sepsis with suspected staphylococcal infection: Flucloxacillin 50 mg/kg QDS IV for 7-10 days (3 weeks for meningitis) plus gentamicin 1

Penicillin Allergy Considerations

Critical distinction: The question mentions penicillin allergy, but cloxacillin/dicloxacillin ARE penicillins (penicillinase-resistant penicillins) and are absolutely contraindicated in patients with true penicillin allergy 1

Alternative Agents for Penicillin-Allergic Patients:

  • For non-immediate hypersensitivity reactions: Cephalexin 25-50 mg/kg/day in 3-4 divided doses orally, or cefazolin 50 mg/kg/day in 3 divided doses IV 1
  • For immediate hypersensitivity or severe allergy: Clindamycin 20-30 mg/kg/day in 3 divided doses orally for mild infections, or 25-40 mg/kg/day in 3 divided doses IV for severe infections 1
  • For MRSA coverage in allergic patients: Vancomycin 40 mg/kg/day in 4 divided doses IV (not to exceed 2 grams/day) 1

Specific Clinical Scenarios

Skin and Soft Tissue Infections (MSSA):

  • Mild outpatient cases: Cephalexin preferred over dicloxacillin in pediatrics (25-50 mg/kg/day in 4 divided doses) 1
  • Severe cases requiring hospitalization: Nafcillin or oxacillin 100-150 mg/kg/day in 4 divided doses IV is the parenteral drug of choice 1

Bacterial Lymphadenitis:

  • Recent evidence demonstrates oral cloxacillin is non-inferior to amoxicillin-clavulanic acid for uncomplicated pediatric bacterial lymphadenitis, with mean defervescence time of 5.74 days 2

Critical Pitfalls to Avoid

  • Never use cloxacillin/dicloxacillin in patients with documented penicillin allergy - this is a penicillin derivative and cross-reactivity is expected 1
  • Inactive against MRSA - if community-acquired MRSA is suspected based on local epidemiology, purulent drainage, or treatment failure, switch to clindamycin, trimethoprim-sulfamethoxazole, or vancomycin 1
  • Not first-line in U.S. pediatric practice - cephalexin has largely replaced dicloxacillin due to better palatability and dosing convenience 1
  • Neonatal dosing differs significantly - the doses listed above are not appropriate for neonates; refer to specialized neonatal dosing guidelines 1

Monitoring and Follow-up

  • Reassess within 48-72 hours of initiating therapy to evaluate clinical response 1
  • Treatment failure indicators: Persistent fever beyond 48-72 hours, worsening erythema, or development of systemic symptoms warrant consideration of resistant organisms or alternative diagnoses 1
  • Renal impairment: Dose adjustment may be necessary as cloxacillin half-life is prolonged in renal dysfunction 3

Related Questions

What are the common antibiotic dosages for pediatric patients?
Is amoxicillin (amoxicillin) suitable for an adult patient with lymphadenitis and no known allergies or sensitivities?
What is the recommended antibiotic for bacterial lymphadenopathy?
What is the recommended oral antibiotic for pediatric patients with bacterial gastroenteritis?
What is the recommended dose of Amiclav (amoxicillin/clavulanic acid) for a pediatric patient with lymphadenitis?
What is the recommended treatment for an adult patient with preseptal cellulitis and no history of penicillin allergy?
What is the recommended dosage and usage of dexmethylphenidate (Focalin) for a young adult without cardiopathy (heart disease)?
What is the likely cause of tongue swelling in a 28-year-old patient with a history of heart failure, currently being treated with Entresto (sacubitril/valsartan), carvedilol, and furosemide, and could it be due to Entresto or amyloidosis?
What are the potential interactions between dexmethylphenidate (a central nervous system stimulant) and trazodone (an antidepressant) in a young adult with Attention Deficit Hyperactivity Disorder (ADHD)?
What management approach would you recommend for an elderly female with decreased bowel movement one week post laparotomy for small bowel obstruction (SBO), currently on parenteral nutrition (PN) via Percutaneous Endoscopic Gastrostomy (PEG)?
Can abemaciclib (CDK4/6 inhibitor) be started without a bone-targeting agent in a patient with high-risk hormone-positive breast cancer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.